Thomas Wessel compensation by year
RELMADA THERAPEUTICS Summary Compensation Table · the one fiscal year held| Component | FY2020 |
|---|---|
| Salary | $384,549 |
| Bonus | $50,000 |
| Stock awards | $0 |
| Option awards | $483,762 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $266,440 |
| Total | $1,184,751 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RELMADA THERAPEUTICS, INC. DEF 14A filed March 31, 2021, accession 0001213900-21-019299, and prior-year filings. Open the filing on EDGAR.
How this page was built: the RELMADA THERAPEUTICS, INC. filed document, accession 0001213900-21-019299. Every figure is read from that document and cited to the page and table it appears in. Filed March 31, 2021.
RELMADA THERAPEUTICS’s named executive officers, FY2020
as the company reported each| Named executive officer | Role | FY2020 total |
|---|---|---|
| Thomas Wessel · this page | Executive VP and Head of R&D | $1,184,751 |
| Sergio Traversa | Chief Executive Officer and Director | $900,000 |
| Maged Shenouda | Chief Financial Officer | $676,750 |
| Charles Ence | Chief Accounting and Compliance Officer | $453,750 |
| Ottavio Vitolo | Senior Vice President, Head | $313,415 |
The full RELMADA THERAPEUTICS compensation record
free company briefThis page is one person within RELMADA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the RELMADA THERAPEUTICS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are RELMADA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.